TipRanks
Advertisement
Advertisement

LEGN Stock Latest News

Legend Biotech Names Novartis Veteran Ingrid Zhang as CEO to Lead Next Phase of CAR-T Growth
Company AnnouncementsLegend Biotech Names Novartis Veteran Ingrid Zhang as CEO to Lead Next Phase of CAR-T Growth
6d ago
6K
LEGN
Legend Biotech appoints Ingrid Zhang as CEO
PremiumThe Fly
Legend Biotech appoints Ingrid Zhang as CEO
6d ago
NVS
LEGN
Legend Biotech Updates and Expands Cell Therapy Clinical Pipeline
PremiumCompany Announcements
Legend Biotech Updates and Expands Cell Therapy Clinical Pipeline
7d ago
6K
LEGN
Legend Biotech price target lowered to $74 from $78 at Barclays
PremiumThe Fly
Legend Biotech price target lowered to $74 from $78 at Barclays
10d ago
LEGN
Legend Biotech Earnings Call Signals Profitable Growth
PremiumCompany Announcements
Legend Biotech Earnings Call Signals Profitable Growth
1M ago
LEGN
Legend Biotech Sets September 24, 2026 AGM With Expanded Equity Plan on Agenda
PremiumCompany AnnouncementsLegend Biotech Sets September 24, 2026 AGM With Expanded Equity Plan on Agenda
1M ago
6K
LEGN
Legend Biotech price target lowered to $24 from $29 at TD Cowen
Premium
The Fly
Legend Biotech price target lowered to $24 from $29 at TD Cowen
1M ago
LEGN
Legend Biotech price target lowered to $78 from $80 at Barclays
Premium
The Fly
Legend Biotech price target lowered to $78 from $80 at Barclays
1M ago
LEGN
Legend Biotech downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
Legend Biotech downgraded to Perform from Outperform at Oppenheimer
1M ago
LEGN
Oppenheimer downgrades Legend Biotech to Perform on CEO/competition overhangs
PremiumThe Fly
Oppenheimer downgrades Legend Biotech to Perform on CEO/competition overhangs
1M ago
JNJ
LEGN
Legend Biotech price target raised to $49 from $48 at Morgan Stanley
PremiumThe Fly
Legend Biotech price target raised to $49 from $48 at Morgan Stanley
1M ago
LEGN
Okta upgraded, Gap downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Okta upgraded, Gap downgraded: Wall Street’s top analyst calls
1M ago
BSP
GAP
Legend Biotech Swings to Profit as CARVYKTI Sales Surge and Pipeline Delivers Key Milestones
PremiumCompany AnnouncementsLegend Biotech Swings to Profit as CARVYKTI Sales Surge and Pipeline Delivers Key Milestones
1M ago
6K
LEGN
Legend Biotech reports Q2 EPS 16c vs. 3c last year
Premium
The Fly
Legend Biotech reports Q2 EPS 16c vs. 3c last year
1M ago
LEGN
LEGN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
LEGN Upcoming Earnings Report: What to Expect?
1M ago
LEGN
Legend Biotech Details Compensation Package for Interim CEO Alan Bash
PremiumCompany Announcements
Legend Biotech Details Compensation Package for Interim CEO Alan Bash
2M ago
6K
LEGN
Buy Rating Reiterated as Strong CARVYKTI Momentum and Attractive Valuation Support Unchanged $65 Price Target
PremiumRatings
Buy Rating Reiterated as Strong CARVYKTI Momentum and Attractive Valuation Support Unchanged $65 Price Target
2M ago
LEGN
Legend Biotech falls -15.1%
PremiumThe Fly
Legend Biotech falls -15.1%
2M ago
LEGN
Legend Biotech falls -12.5%
PremiumThe Fly
Legend Biotech falls -12.5%
2M ago
LEGN
Legend Biotech price target lowered to $59 from $63 at RBC Capital
PremiumThe FlyLegend Biotech price target lowered to $59 from $63 at RBC Capital
2M ago
LEGN
Legend Biotech Names CARVYKTI President Alan Bash Interim CEO After Ying Huang Resigns
Premium
Company Announcements
Legend Biotech Names CARVYKTI President Alan Bash Interim CEO After Ying Huang Resigns
2M ago
6K
LEGN
Legend Biotech CEO Ying Huang steps down, Alan Bash named interim CEO
Premium
The Fly
Legend Biotech CEO Ying Huang steps down, Alan Bash named interim CEO
2M ago
LEGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >